In the field of molecular imaging, in vivo preclinical imaging has become increasingly important to academic researchers and especially to those involved indrug development and it is increasingly recognized as an important facet of preclinical and translational biology research. Imaging animal models has had a dramatic impact on how drugs are discovered and developed by providing real time data on efficacy, biodistribution, and kinetics at all stages of disease and in relevant animal models that are predictive of the human response. Preclinical imaging enables the most powerful and clinically translatable methods for monitoring disease progression currently possible.
Imaging tools can help better assess anatomy and disease morphology, physiological and functional parameters, and molecular and cellular processes. We offer a comprehensive and sophisticated preclinical imaging portfolio for a broad spectrum of application fields, such as cancer research, functional and anatomical neuroimaging, orthopedics, cardiac imaging, stroke models and inflammatory.
Members of the nanoScan Family developed and manufactured by Mediso combine the industry’s highest performing microscopy level of molecular imaging (PET, SPECT) supported by excellent MRI and CT performance. Read more about our small animal imaging systems…